M-MDSCs are recruited to the TME primarily by tumor-derived CCL2 and CCL5, while PMN-MDSCs are recruited by CCL2 and CCL3 (Qian et al., 2011; Reichel et al., 2012; Chun et al., 2015). The gene discussed is CCL2; the disease is neoplasm.